# A Long-term Follow-up Study of Patients Who Received MB-105

Source: https://onco.cc/trials/nct07340814/  
OnCo record `nct07340814` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An trial of MB-105 run by March Biosciences Inc, not yet recruiting.

## Summary

A Long-term Follow-up Study of Patients Who Received MB-105 is an interventional study registered as NCT07340814 by March Biosciences Inc, with 40 participants planned, started 2026-02-27. Conditions recorded: Any Patient Treated With MB-105. Interventions recorded: MB-105.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07340814
- Phase: not-applicable
- Setting: A Long-term Follow-up Study of Patients Who Received MB-105
- Sponsor: March Biosciences Inc
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT07340814: https://clinicaltrials.gov/study/NCT07340814

## Connected records

- drugs: [MB-105](https://onco.cc/drugs/mb-105/)
- companies: [March Biosciences](https://onco.cc/companies/march-biosciences/)

---
JSON: https://onco.cc/api/v1/entities/nct07340814.json